{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:58:00Z","timestamp":1773287880843,"version":"3.50.1"},"reference-count":117,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Pregestational diabetes (PGDM) is an increasingly common and complex condition that infers risk to both mother and infant. To prevent serious morbidity, strict glycaemic control is essential. The aim of this review is to review the glucose sensing and insulin delivering technologies currently available for women with PGDM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We reviewed online databases for articles relating to technology use in pregnancy using a combination of keywords and MeSH headings. Relevant articles are included below.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A number of technological advancements have improved care and outcomes for women with PGDM. Real time continuous glucose monitoring (rtCGM) offers clear advantages in terms of infants size and neonatal intensive care unit admissions; and further benefits are seen when combined with continuous subcutaneous insulin delivery (insulin pump) and algorithms which continuously adjust insulin levels to glucose targets (hybrid closed loop). Other advancements including flash or intermittent scanning CGM (isCGM) and stand-alone insulin pumps do not confer as many advantages for women and their infants, however they are increasingly used outside of pregnancy and many women enter pregnancy already using these devices.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This article offers a discussion of the most commonly used technologies in pregnancy and evaluates their current and future roles.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.1109825","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T04:52:50Z","timestamp":1673499170000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Glycaemic control and novel technology management strategies in pregestational diabetes mellitus"],"prefix":"10.3389","volume":"13","author":[{"given":"Christine","family":"Newman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adesuwa","family":"Ero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fidelma P.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"109049","DOI":"10.1016\/j.diabres.2021.109049","article-title":"IDF diabetes atlas: The prevalence of pre-existing diabetes in pregnancy - a systematic reviewand meta-analysis of studies published during 2010-2020","volume":"183","author":"Chivese","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009494","article-title":"A cohort study of trends in the prevalence of pregestational diabetes in pregnancy recorded in UK general practice between 1995 and 2012","volume":"6","author":"Coton","year":"2016","journal-title":"BMJ Open"},{"key":"B3","doi-asserted-by":"publisher","first-page":"108685","DOI":"10.1016\/j.diabres.2021.108685","article-title":"Diabetes care and pregnancy outcomes for women with pregestational diabetes in Ireland","volume":"173","author":"Newman","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30406-X","article-title":"Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study","volume":"9","author":"Murphy","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S2213-8587(17)30186-9","article-title":"Type 2 diabetes in adolescents and young adults","volume":"6","author":"Lascar","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2021.12.021","article-title":"Obesity incidence in U.S. children and young adults: A pooled analysis","volume":"63","author":"Rafei","year":"2022","journal-title":"Am J Prev Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13098-016-0186-9","article-title":"Factors that could explain the increasing prevalence of type 2 diabetes among adults in a Canadian province: a critical review and analysis","volume":"8","author":"Thibault","year":"2016","journal-title":"Diabetol Metab Syndrome"},{"key":"B8","volume-title":"SEARCH for diabetes in youth study","year":"2020"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.4981","article-title":"Management of preexisting diabetes in pregnancy: A review","volume":"321","author":"Alexopoulos","year":"2019","journal-title":"Jama"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17824","article-title":"Quantitative assessment of the effect of pre-gestational diabetes and risk of adverse maternal, perinatal and neonatal outcomes","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4688-x","article-title":"Associations of maternal type 1 diabetes with childhood adiposity and metabolic health in the offspring: a prospective cohort study","volume":"61","author":"Pitchika","year":"2018","journal-title":"Diabetologia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"l6398","DOI":"10.1136\/bmj.l6398","article-title":"Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up","volume":"367","author":"Yu","year":"2019","journal-title":"BMJ"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-4923-0","article-title":"Neurocognitive and behavioural outcomes in offspring exposed to maternal pre-existing diabetes: a systematic review and meta-analysis","volume":"62","author":"Yamamoto","year":"2019","journal-title":"Diabetologia"},{"key":"B14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1001\/jama.2018.7614","article-title":"Maternal type 1 diabetes and risk of autism in offspring","volume":"320","author":"Xiang","year":"2018","journal-title":"Jama"},{"key":"B15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12887-019-1509-4","article-title":"Follow-up study of neurodevelopment in 2-year-old infants who had suffered from neonatal hypoglycemia","volume":"19","author":"Qiao","year":"2019","journal-title":"BMC Pediatr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2337\/db22-248-OR","article-title":"248-OR: MiTy kids: Follow-up of offspring exposed to metformin in-utero in mothers with type 2 diabetes in the MiTy trial","volume":"71","author":"Feig","year":"2022","journal-title":"Diabetes"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-SINT","article-title":"15. management of diabetes in pregnancy: Standards of medical care in diabetes\u20132022","volume":"45","year":"2021","journal-title":"Diabetes Care"},{"key":"B18","volume-title":"Guidelines, in diabetes in pregnancy: management from preconception to the postnatal period. 2020","year":"2020"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-013-3108-5","article-title":"Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study","volume":"57","author":"Tennant","year":"2014","journal-title":"Diabetologia"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2455-y","article-title":"Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study","volume":"55","author":"Bell","year":"2012","journal-title":"Diabetologia"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4046","article-title":"A prepregnancy care program for women with diabetes: Effective and cost saving","volume":"101","author":"Egan","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237571","article-title":"Systematic review and meta-analysis of the effectiveness of pre-pregnancy care for women with diabetes for improving maternal and perinatal outcomes","volume":"15","author":"Wahabi","year":"2020","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1093841","article-title":"The artificial beta cell\u2013a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system)","volume":"6","author":"Pfeiffer","year":"1974","journal-title":"Horm Metab Res"},{"key":"B24","first-page":"23","article-title":"The development of biostator, a glucose controlled insulin infusion system (GCIIS)","author":"Clemens","year":"1977","journal-title":"Horm Metab Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/24.8.1366","article-title":"Development and evaluation of a glucose analyzer for a glucose controlled insulin infusion system ((Biostator)","volume":"24","author":"Fogt","year":"1978","journal-title":"Clin Chem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/BF01223159","article-title":"Continuous subcutaneous insulin infusion:good blood glucose control for up to 4 days","volume":"16","author":"Pickup","year":"1979","journal-title":"Diabetologia"},{"key":"B27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2337\/diab.28.1.71","article-title":"Closed-loop and open-loop devices for blood glucose control in normal and diabetic subjects","volume":"28","author":"Santiago","year":"1978","journal-title":"Diabetes"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00212-1","article-title":"Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study","volume":"10","author":"Choudhary","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8227(11)70007-9","article-title":"The story of insulin discovery","author":"Karamitsos","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3402\/jchimp.v2i2.18701","article-title":"History of insulin","volume":"2","author":"Quianzon","year":"2012","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1177\/193229680900300446","article-title":"Glucose meters: a review of technical challenges to obtaining accurate results","volume":"3","author":"Tonyushkina","year":"2009","journal-title":"J Diabetes Sci Technol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2009.01048.x","article-title":"Insulin pumps: from inception to the present and toward the future","volume":"35","author":"Alsaleh","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1177\/193229681000400302","article-title":"Evolution of diabetes insulin delivery devices","volume":"4","author":"Selam","year":"2010","journal-title":"J Diabetes Sci Technol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(94)70190-3.","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"New Engl J Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2017.09.005","article-title":"A history of continuous glucose monitors (CGMs) in self-monitoring of diabetes mellitus","volume":"12","author":"Olczuk","year":"2018","journal-title":"Diabetes Metab Syndrome: Clin Res Rev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1303576","article-title":"Threshold-based insulin-pump interruption for reduction of hypoglycemia","volume":"369","author":"Bergenstal","year":"2013","journal-title":"New Engl J Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1248","article-title":"Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase","volume":"34","author":"Bergenstal","year":"2011","journal-title":"Diabetes Care"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2708-9","article-title":"The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial","volume":"55","author":"Battelino","year":"2012","journal-title":"Diabetologia"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)31535-5","article-title":"Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial","volume":"388","author":"Bolinder","year":"2016","journal-title":"Lancet"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-020-00823-z","article-title":"The do-It-Yourself artificial pancreas: A comprehensive review","volume":"11","author":"Kesavadev","year":"2020","journal-title":"Diabetes Ther"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0202","article-title":"Retrospective analysis of 3-month real-world glucose data after the MiniMed 670G system commercial launch","volume":"20","author":"Stone","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1907863","article-title":"Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes","volume":"381","author":"Brown","year":"2019","journal-title":"New Engl J Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2205225.","article-title":"Multicenter, randomized trial of a bionic pancreas in type 1 diabetes","volume":"387","year":"2022","journal-title":"New Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203913","article-title":"Open-source automated insulin delivery in type 1 diabetes","volume":"387","author":"Burnside","year":"2022","journal-title":"New Engl J Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2205650","article-title":"Intermittently scanned continuous glucose monitoring for type 1 diabetes","volume":"387","author":"Leelarathna","year":"2022","journal-title":"New Engl J Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.19975","article-title":"Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: The DIAMOND randomized clinical trial","volume":"317","author":"Beck","year":"2017","journal-title":"Jama"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12246","article-title":"Real-time continuous glucose monitoring during labour and delivery in women with type 1 diabetes - observations from a randomized controlled trial","volume":"30","author":"Cordua","year":"2013","journal-title":"Diabetes Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13098-020-00529-z","article-title":"Time in range: a new parameter to evaluate blood glucose control in patients with diabetes","volume":"12","author":"Gabbay","year":"2020","journal-title":"Diabetol Metab Syndrome"},{"key":"B49","doi-asserted-by":"publisher","first-page":"a1680","DOI":"10.1136\/bmj.a1680","article-title":"Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial","volume":"337","author":"Murphy","year":"2008","journal-title":"BMJ"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32400-5","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial","volume":"390","author":"Feig","year":"2017","journal-title":"Lancet"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13988","article-title":"Maternal glycaemic control and risk of neonatal hypoglycaemia in type 1 diabetes pregnancy: a secondary analysis of the CONCEPTT trial","volume":"36","author":"Yamamoto","year":"2019","journal-title":"Diabetes Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-0070","article-title":"Analysis of continuous glucose monitoring in pregnant women with diabetes: Distinct temporal patterns of glucose associated with Large-for-Gestational-Age infants","volume":"38","author":"Law","year":"2015","journal-title":"Diabetes Care"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-0078","article-title":"Continuous glucose monitoring metrics and birth weight: Informing management of type 1 diabetes throughout pregnancy","volume":"45","author":"Scott","year":"2022","journal-title":"Diabetes Care"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab502","article-title":"Achieving the HbA1c target requires longer time in range in pregnant women with type 1 diabetes","volume":"106","author":"Ling","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B55","doi-asserted-by":"publisher","first-page":"E627","DOI":"10.9778\/cmajo.20200128","article-title":"The cost implications of continuous glucose monitoring in pregnant women with type 1 diabetes in 3 Canadian provinces: a posthoc cost analysis of the CONCEPTT trial","volume":"9","author":"Ahmed","year":"2021","journal-title":"CMAJ Open"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14046","article-title":"Modelling potential cost savings from use of real-time continuous glucose monitoring in pregnant women with type 1 diabetes","volume":"36","author":"Murphy","year":"2019","journal-title":"Diabetes Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13310","article-title":"Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): A multicentre randomized controlled trial","volume":"20","author":"Voormolen","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2360","article-title":"The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial","volume":"36","author":"Secher","year":"2013","journal-title":"Diabetes Care"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1177\/193229681300700408","article-title":"Susceptibility of interstitial continuous glucose monitor performance to sleeping position","volume":"7","author":"Mensh","year":"2013","journal-title":"J Diabetes Sci Technol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2011.03426.x","article-title":"Patient satisfaction and barriers to initiating real-time continuous glucose monitoring in early pregnancy in women with diabetes","volume":"29","author":"Secher","year":"2012","journal-title":"Diabetic Med J Br Diabetic Assoc"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.2337\/db19-1424-P","article-title":"1424-p: Changes in device uptake and glycemic control among pregnant women with type 1 diabetes: Data from the T1D exchange","volume":"68","author":"Levy","year":"2019","journal-title":"Diabetes"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230476","article-title":"Continuous glucose monitor use with and without remote monitoring in pregnant women with type 1 diabetes: A pilot study","volume":"15","author":"Polsky","year":"2020","journal-title":"PloS One"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30263-3","article-title":"The CGM grey market: a reflection of global access inequity","volume":"7","author":"Onisie","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2337\/cd20-0076","article-title":"3rd, flash continuous glucose monitoring: A summary review of recent real-world evidence","volume":"39","author":"Bailey","year":"2021","journal-title":"Clin Diabetes"},{"key":"B65","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1932296816662047","article-title":"Significance and reliability of MARD for the accuracy of CGM systems","volume":"11","author":"Reiterer","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2017.0386","article-title":"Accuracy, user acceptability, and safety evaluation for the FreeStyle libre flash glucose monitoring system when used by pregnant women with diabetes","volume":"20","author":"Scott","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"B67","year":""},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2016.0392","article-title":"A clinical trial of the accuracy and treatment experience of the flash glucose monitor FreeStyle libre in adults with type 1 diabetes","volume":"19","author":"\u00d3lafsd\u00f3ttir","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2021.03.013","article-title":"Efficacy of flash glucose monitoring in pregnant women with poorly controlled pregestational diabetes (FlashMom): A randomized pilot study","volume":"31","author":"Tumminia","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B70","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13098-021-00657-0","article-title":"Effects of intermittently scanned continuous glucose monitoring on blood glucose control and the production of urinary ketone bodies in pregestational diabetes mellitus","volume":"13","author":"Li","year":"2021","journal-title":"Diabetol Metab Syndr"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2019.08.001","article-title":"Disagreement between capillary blood glucose and flash glucose monitoring sensor can lead to inadequate treatment adjustments during pregnancy","volume":"46","author":"Sola-Gazagnes","year":"2020","journal-title":"Diabetes Metab"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05717-2","article-title":"Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes","volume":"65","author":"Perea","year":"2022","journal-title":"Diabetologia"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2021.0109","article-title":"Comparison of glycemic metrics measured simultaneously by intermittently scanned continuous glucose monitoring and real-time continuous glucose monitoring in pregnant women with type 1 diabetes","volume":"23","author":"N\u00f8rgaard","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-4850-0","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies","volume":"62","author":"Kristensen","year":"2019","journal-title":"Diabetologia"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2011.0081","article-title":"Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? a pilot study","volume":"13","author":"Petrovski","year":"2011","journal-title":"Diabetes Technol Ther"},{"key":"B76","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1089\/dia.2020.0667","article-title":"Benefits of real-time continuous glucose monitoring in pregnancy","volume":"23","author":"Yamamoto","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"B77","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.dsx.2013.02.032","article-title":"Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment","volume":"7","author":"Talaviya","year":"2013","journal-title":"Diabetes Metab Syndr"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2016.0412","article-title":"Pregnancy outcomes and insulin requirements in women with type 1 diabetes treated with continuous subcutaneous insulin infusion and multiple daily injections: Cohort study","volume":"19","author":"Abell","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3163-6","article-title":"Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes","volume":"57","author":"Kallas-Koeman","year":"2014","journal-title":"Diabetologia"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2011.02.002","article-title":"Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI)","volume":"37","author":"Bruttomesso","year":"2011","journal-title":"Diabetes Metab"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2015.0165","article-title":"Continuous subcutaneous insulin infusion during pregnancy in women with complicated type 1 diabetes is associated with better glycemic control but not with improvement in pregnancy outcomes","volume":"18","author":"Kek\u00e4l\u00e4inen","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.12027","article-title":"Multiple daily injections of insulin versus continuous subcutaneous insulin infusion for pregnant women with type 1 diabetes","volume":"53","author":"Wender-Ozegowska","year":"2013","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0804","article-title":"Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies","volume":"178","author":"Rys","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005542.pub3","article-title":"Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes","author":"Farrar","year":"2016","journal-title":"Cochrane Database Systematic Rev"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13861","article-title":"Higher rates of large-for-gestational-age newborns mediated by excess maternal weight gain in pregnancies with type 1 diabetes and use of continuous subcutaneous insulin infusion vs multiple dose insulin injection","volume":"36","author":"Hauffe","year":"2019","journal-title":"Diabetic Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1437","article-title":"Pumps or multiple daily injections in pregnancy involving type 1 diabetes: A prespecified analysis of the CONCEPTT randomized trial","volume":"41","author":"Feig","year":"2018","journal-title":"Diabetes Care"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.14039","article-title":"Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - pump vs multiple daily injections, a secondary analysis of an observational cohort study","volume":"100","author":"Kj\u00f6lhede","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13106","article-title":"Insulin pump use compared with intravenous insulin during labour and delivery: the INSPIRED observational cohort study","volume":"33","author":"Drever","year":"2016","journal-title":"Diabetes Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1177\/1932296816672689","article-title":"Sensor-augmented insulin pumps and hypoglycemia prevention in type 1 diabetes","volume":"11","author":"Steineck","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.919942","article-title":"Closed-loop insulin delivery systems: Past, present, and future directions","volume":"13","author":"Templer","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2017.0030","article-title":"Maternal-fetal outcomes in 34 pregnant women with type 1 diabetes in sensor-augmented insulin pump therapy","volume":"19","author":"G\u00f3mez","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.5603\/GP.a2021.0029","article-title":"Continuous glucose monitoring and insulin pump therapy in pregnant women with type 1 diabetes mellitus","volume":"92","author":"Lason","year":"2021","journal-title":"Ginekol Pol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-021-05589-y","article-title":"Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT","volume":"64","author":"Benhalima","year":"2021","journal-title":"Diabetologia"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1796","article-title":"Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes","volume":"34","author":"Murphy","year":"2011","journal-title":"Diabetes Care"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1430","article-title":"Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series","volume":"35","author":"Murphy HR","year":"2012","journal-title":"Diabetes Care"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602494","article-title":"Closed-loop insulin delivery during pregnancy in women with type 1 diabetes","volume":"375","author":"Stewart","year":"2016","journal-title":"N Engl J Med"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-2534","article-title":"Day-and-Night closed-loop insulin delivery in a broad population of pregnant women with type 1 diabetes: A randomized controlled crossover trial","volume":"41","author":"Stewart","year":"2018","journal-title":"Diabetes Care"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0060","article-title":"Adaptability of closed loop during labor, delivery, and postpartum: A secondary analysis of data from two randomized crossover trials in type 1 diabetes pregnancy","volume":"20","author":"Stewart","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-2762","article-title":"User engagement with the CamAPS FX hybrid closed-loop app according to age and user characteristics","volume":"44","author":"Chen","year":"2021","journal-title":"Diabetes Care"},{"key":"B100","doi-asserted-by":"publisher","first-page":"7310176","DOI":"10.1155\/2021\/7310176","article-title":"The closed-loop system improved the control of a pregnant patient with type 1 diabetes mellitus","volume":"2021","author":"Guzm\u00e1n G\u00f3mez","year":"2021","journal-title":"Case Rep Endocrinol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2021.0521","article-title":"Feasibility of closed-loop insulin delivery with a pregnancy-specific zone model predictive control algorithm","volume":"24","author":"Ozaslan","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"B102","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12884-022-04543-z","article-title":"AiDAPT: automated insulin delivery amongst pregnant women with type 1 diabetes: a multicentre randomized controlled trial \u2013 study protocol","volume":"22","author":"Lee","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1177\/1932296818800065","article-title":"Women's experiences of day-and-Night closed-loop insulin delivery during type 1 diabetes pregnancy","volume":"12","author":"Farrington","year":"2018","journal-title":"J Diabetes Sci Technol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1177\/193229681300700324","article-title":"\"Turn it off!\": diabetes device alarm fatigue considerations for the present and the future","volume":"7","author":"Shivers","year":"2013","journal-title":"J Diabetes Sci Technol"},{"key":"B105","article-title":"Telehealth systems","volume-title":"StatPearls","author":"Mechanic","year":"2022"},{"key":"B106","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/bmjinnov-2020-000440","article-title":"Telemedicine takes centre stage during COVID-19 pandemic","volume":"6","author":"Ahmed","year":"2020","journal-title":"BMJ Innov"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.2196\/30042","article-title":"Use of patient-reported outcome measures and patient-reported experience measures within evaluation studies of telemedicine applications: Systematic review","volume":"23","author":"Knapp","year":"2021","journal-title":"J Med Internet Res"},{"key":"B108","doi-asserted-by":"publisher","first-page":"19322968221094626","DOI":"10.1177\/19322968221094626","article-title":"Effectiveness of telemedicine in managing diabetes in pregnancy: A systematic review and meta-analysis","volume":"17","author":"Laursen","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2014.0223","article-title":"Web-based telemedicine system is useful for monitoring glucose control in pregnant women with diabetes","volume":"17","author":"Carral","year":"2015","journal-title":"Diabetes Technol Ther"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1258\/jtt.2009.081213","article-title":"The effect of telemedicine on outcome and quality of life in pregnant women with diabetes","volume":"15","author":"Dalfr\u00e0","year":"2009","journal-title":"J Telemed Telecare"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1089\/15209150152811207","article-title":"What we can really expect from telemedicine in intensive diabetes treatment: results from 3-year study on type 1 pregnant diabetic women","volume":"3","author":"Wojcicki","year":"2001","journal-title":"Diabetes Technol Ther"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-020-00980-1","article-title":"Smart insulin pens are associated with improved clinical outcomes at lower cost versus standard-of-Care treatment of type 1 diabetes in Sweden: A cost-effectiveness analysis","volume":"12","author":"Jendle","year":"2021","journal-title":"Diabetes Ther"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820983863","article-title":"Digital diabetes management: A literature review of smart insulin pens","volume":"16","author":"Heinemann","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"19322968211033837","DOI":"10.1177\/19322968211033837","article-title":"Efficacy of a smart insulin pen cap for the management of patients with uncontrolled type 2 diabetes: A randomized cross-over trial","author":"Galindo","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e22074","DOI":"10.2196\/22074","article-title":"Carbohydrate counting app using image recognition for youth with type 1 diabetes: Pilot randomized control trial","volume":"8","author":"Alfonsi","year":"2020","journal-title":"JMIR Mhealth Uhealth"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-021-01082-2","article-title":"Prospective independent evaluation of the carbohydrate counting accuracy of two smartphone applications","volume":"12","author":"Joubert","year":"2021","journal-title":"Diabetes Ther"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2017.0235","article-title":"The use of mobile applications among adults with type 1 and type 2 diabetes: Results from the second MILES-Australia (MILES-2) study","volume":"19","author":"Trawley","year":"2017","journal-title":"Diabetes Technol Ther"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1109825\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T04:52:55Z","timestamp":1673499175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1109825\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":117,"alternative-id":["10.3389\/fendo.2022.1109825"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1109825","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]},"article-number":"1109825"}}